Association between CD40 rs1883832 and immune-related diseases susceptibility: A meta-analysis.

Qin, Jiaxuan; Xing, Jinchun; Liu, Rongfu; Chen, Bin; Chen, Yuedong; Zhuang, Xuan

Qin, Jiaxuan; Xing, Jinchun; Liu, Rongfu; Chen, Bin; Chen, Yuedong; Zhuang, Xuan.

Affiliation

Qin J; Department of Urology Surgery, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, 361003, China.
Xing J; Center of Diagnosis and Treatment of Urinary System Diseases, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, 361003, China.
Liu R; The Key Laboratory of Urinary Tract Tumors and Calculi, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, 361003, China.
Chen B; Department of Urology Surgery, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, 361003, China.
Chen Y; Center of Diagnosis and Treatment of Urinary System Diseases, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, 361003, China.
Zhuang X; The Key Laboratory of Urinary Tract Tumors and Calculi, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, 361003, China.

Oncotarget ; 8(60): 102235-102243, 2017 Nov 24.

Article de En | MEDLINE | ID: mdl-29254239

Mots clés

CD40; SNP; immune-related disease; meta-analysis; rs1883832

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Observational_studies / Risk_factors_studies / Systematic_reviews Langue: En Journal: Oncotarget Année: 2017 Type de document: Article Pays d'affiliation: Chine Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google